Temporal arteritis risk factors: Difference between revisions
Hamid Qazi (talk | contribs) |
Hamid Qazi (talk | contribs) |
||
Line 20: | Line 20: | ||
The risk factors of temporal arteritis are as follows: | The risk factors of temporal arteritis are as follows: | ||
===Common Risk Factors=== | ===Common Risk Factors=== | ||
*Common risk factors in the development of temporal arteritis may be environmental, genetic, and viral. | *Common risk factors in the development of temporal arteritis may be environmental, genetic, and viral. |
Revision as of 14:04, 9 April 2018
Temporal Arteritis Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Temporal arteritis risk factors On the Web |
American Roentgen Ray Society Images of Temporal arteritis risk factors |
Risk calculators and risk factors for Temporal arteritis risk factors |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Hamid Qazi, MD, BSc [2]
Overview
There are no established risk factors for [disease name].
OR
The most potent risk factor in the development of [disease name] is [risk factor 1]. Other risk factors include [risk factor 2], [risk factor 3], and [risk factor 4].
OR
Common risk factors in the development of [disease name] include [risk factor 1], [risk factor 2], [risk factor 3], and [risk factor 4].
OR
Common risk factors in the development of [disease name] may be occupational, environmental, genetic, and viral.
Risk Factors
The risk factors of temporal arteritis are as follows:
Common Risk Factors
- Common risk factors in the development of temporal arteritis may be environmental, genetic, and viral.
- Common risk factors in the development of temporal arteritis include:[1][2][3]
- Age
- Hypertension
- Thrombocytosis
Less Common Risk Factors
- Less common risk factors in the development of temporal arteritis include:[4]
- Allele HLA-DRB1*04 genetic polymorphisms
- Varicella zoster virus infection
- Smoking
References
- ↑ Nesher G, Berkun Y, Mates M, Baras M, Nesher R, Rubinow A; et al. (2004). "Risk factors for cranial ischemic complications in giant cell arteritis". Medicine (Baltimore). 83 (2): 114–22. PMID 15028965.
- ↑ González-Gay MA, García-Porrúa C, Llorca J, Hajeer AH, Brañas F, Dababneh A; et al. (2000). "Visual manifestations of giant cell arteritis. Trends and clinical spectrum in 161 patients". Medicine (Baltimore). 79 (5): 283–92. PMID 11039076.
- ↑ Salvarani C, Cimino L, Macchioni P, Consonni D, Cantini F, Bajocchi G; et al. (2005). "Risk factors for visual loss in an Italian population-based cohort of patients with giant cell arteritis". Arthritis Rheum. 53 (2): 293–7. doi:10.1002/art.21075. PMID 15818722.
- ↑ Mahr, A.; Aouba, A.; Richebé, P.; Gonzalez-Chiappe, S. (2017). "Épidémiologie et histoire naturelle de l'artérite à cellules géantes (Horton)". La Revue de Médecine Interne. 38 (10): 663–669. doi:10.1016/j.revmed.2017.03.007. ISSN 0248-8663.